Vector-borne diseases (VBDs) pose a significant public health challenge in India, with an escalating incidence and geographical spread. These diseases, transmitted by vectors such as mosquitoes, ticks, and fleas, include malaria, dengue, chikungunya, and zika virus.
Over the past decade, there has been a marked increase in the incidence of VBDs in India. This escalation is attributed to several factors including urbanization, climate change, and increased travel and trade. Additionally, the geographical spread of these diseases has widened, with cases reported from previously unaffected areas.
Efforts to prevent and control VBDs in India face numerous challenges. These include inadequate surveillance systems, limited resources for vector control, and a lack of public awareness about preventive measures. Furthermore, the emergence of vector resistance to insecticides poses a significant hurdle to disease control.
Healthcare professionals play a crucial role in combating VBDs. They are at the forefront of disease detection, management, and prevention. Their responsibilities include early diagnosis and appropriate treatment, as well as educating patients about preventive measures. Furthermore, they can contribute to surveillance efforts by timely reporting of cases.
The escalating threat of VBDs in India calls for a comprehensive and coordinated response. Enhancing surveillance, improving vector control measures, and raising public awareness are key strategies. Healthcare professionals have a pivotal role in this endeavor. Continued research and collaboration are essential to counter this public health challenge.
1.
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation
2.
Can Fasting Around Chemo Improve Ovarian Cancer Outcomes?
3.
Chemo causes lasting physical decline in breast cancer survivors
4.
MRI-guided radiation therapy improves quality of life with fewer side effects in patients with localized cancer. JAMA
5.
BMI is linked to heart damage from chemotherapy in breast cancer patients.
1.
The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond
2.
Rehabilitation Following Bone Marrow Functional Suppression: Clinical Strategies and Advances
3.
Unlocking the Potential of Cancer Antigen 19-9 for Early Detection
4.
Strategic Breakthroughs in Oncology in Clinical Decision-Making
5.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
2.
Early warning sings of camcer that need medical attention
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation